Current state and prospects of artificial intelligence in allergy

Author:

van Breugel Merlijn123ORCID,Fehrmann Rudolf S. N.4ORCID,Bügel Marnix3,Rezwan Faisal I.56,Holloway John W.57ORCID,Nawijn Martijn C.28,Fontanella Sara910,Custovic Adnan910,Koppelman Gerard H.12

Affiliation:

1. Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital University Medical Center Groningen, University of Groningen Groningen the Netherlands

2. Groningen Research Institute for Asthma and COPD (GRIAC) University Medical Center Groningen, University of Groningen Groningen the Netherlands

3. MIcompany Amsterdam the Netherlands

4. Department of Medical Oncology University Medical Center Groningen, University of Groningen Groningen the Netherlands

5. Human Development and Health, Faculty of Medicine University of Southampton Southampton UK

6. Department of Computer Science Aberystwyth University Aberystwyth UK

7. National Institute for Health and Care Research Southampton Biomedical Research Centre University Hospitals Southampton NHS Foundation Trust Southampton UK

8. Department of Pathology and Medical Biology University Medical Center Groningen, University of Groningen Groningen the Netherlands

9. National Heart and Lung Institute Imperial College London London UK

10. National Institute for Health and Care Research Imperial Biomedical Research Centre (BRC) London UK

Abstract

AbstractThe field of medicine is witnessing an exponential growth of interest in artificial intelligence (AI), which enables new research questions and the analysis of larger and new types of data. Nevertheless, applications that go beyond proof of concepts and deliver clinical value remain rare, especially in the field of allergy. This narrative review provides a fundamental understanding of the core concepts of AI and critically discusses its limitations and open challenges, such as data availability and bias, along with potential directions to surmount them. We provide a conceptual framework to structure AI applications within this field and discuss forefront case examples. Most of these applications of AI and machine learning in allergy concern supervised learning and unsupervised clustering, with a strong emphasis on diagnosis and subtyping. A perspective is shared on guidelines for good AI practice to guide readers in applying it effectively and safely, along with prospects of field advancement and initiatives to increase clinical impact. We anticipate that AI can further deepen our knowledge of disease mechanisms and contribute to precision medicine in allergy.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference231 articles.

1. FDA.Artificial intelligence and machine learning (AI/ML)‐enabled medical devices. Accessed December 11 2022.https://www.fda.gov/medical‐devices/software‐medical‐device‐samd/artificial‐intelligence‐and‐machine‐learning‐aiml‐enabled‐medical‐devices

2. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015–20): a comparative analysis

3. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use

4. Artificial intelligence in healthcare: past, present and future

5. Artificial Intelligence in Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3